agle-ex231_44.htm

EX-23.1 3 agle-ex231_44.htm EX-23.1 agle-ex231_44.htm

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 23, 2017 relating to the financial statements, which appears in Aeglea BioTherapeutics, Inc.'s Annual Report on Form 10‑K for the year ended December 31, 2016.

/s/ PricewaterhouseCoopers LLP
Austin, Texas
March 23, 2017